Active Immunotherapy to Prevent Alzheimer Disease —A DNA Amyloid β 1-42 Trimer Vaccine

This Viewpoint argues that there is a possibility of finding a path forward in Alzheimer disease prevention with the DNA amyloid β 1-42 timer vaccine that warrants its evaluation in a clinical trial.

Source: JAMA Neurology - December 9, 2019 Category: Neurology Source Type: research